![](/img/cover-not-exists.png)
Preclinical validation of AR42, a novel histone deacetylase inhibitor, as treatment for vestibular schwannomas
Abraham Jacob, Janet Oblinger, Matthew L. Bush, Victoria Brendel, Griffin Santarelli, Abhik R. Chaudhury, Samuel Kulp, Krista M. D. La Perle, Ching-Shih Chen, Long-Sheng Chang, D. Bradley WellingVolume:
122
Year:
2012
Language:
english
Pages:
16
DOI:
10.1002/lary.22392
File:
PDF, 11.63 MB
english, 2012